Singlera Genomics Garners $20,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ac5d3a33-5247-4dbe-9f53-7bdacc2d2c42 - Date
8/24/2016 - Company Name
Singlera Genomics - Mailing Address
505 Coast Blvd S La Jolla, CA 92037 USA - Company Description
Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. - Website
http://www.singleragenomics.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Series A - Proceeds Purposes
The funding will help Singlera expand the development and commercialization of its non-invasive genomic sequencing tests for cancer and other genetic diseases. Singlera will also use the funds to further expand its R&D operations and expedite the launch of new product lines that address tumor diagnosis and personalized treatment. - M&A Terms
- Venture Investor
Lilly Asia Ventures - Venture Investor
Undisclosed
